Drug maker Merck announced Tuesday it will embark on an initiative to cut $3 billion in costs 2027, including an undisclosed ...

The global Cell Culture Market, valued at US$27.92 billion in 2024 stood at US$29.76 billion in 2025 and is projected to advance at a ...

Merck (MRK) announced a bold cost-cutting strategy aiming to save $3 billion annually by 2027, reflecting a major operational ...

The Merck Foundation Health Media Training is a part of ‘Merck Foundation More than a Mother’ Community Awareness Program. Since 2017, Merck Foundation has provided their Health Media Training for ...

Merck is undergoing a strategic restructuring, resulting in immediate job cuts in administration, sales, and research as part of a plan to save $3 billion by 2027.

Merck stock slid after the company’s earnings report failed to ease worries about the impending expiration of the patents ...

Merck Foundation Together with African and Asian First Ladies Mark 'World Assisted Reproductive Technology Day' 2025 ...

Merck Foundation has pioneered a new era in fertility care across Africa and Asia by training local embryologists and ...

Merck Foundation has produced nearly 30 original songs that speak to infertility, female empowerment, and reproductive rights ...

Investors interested in Medical - Drugs stocks are likely familiar with Merck KGaA (MKKGY) and Stevanato Group (STVN). But which of these two stocks offers value investors a better bang for their buck ...